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ABSTRACT 
 
Human Papillomavirus (HPV) is the most common sexually transmitted 
infection (STI) with approximately 79 million Americans currently infected and 14 
million people becoming infected every year (CDC, 2013). About 33,300 HPV 
related cancers are diagnosed every year and affect more women than men 
(CDC, 2012). Two prophylactic HPV vaccines are currently FDA approved and 
recommended by the ACIP: Gardasil, a quadrivalent prophylactic vaccine for 
types 6, 11, 16, and 18, and Cervarix, a bivalent HPV vaccine for types 16 and 
18 (ACIP, 2010). Both vaccines are recommended for girl’s aged 11 or 12 years 
and catch-up vaccination is advised for girls between the ages of 13 and 26 
(ACIP, 2010; Markowitz et al., 2007). 
Understanding parents’ opinions about HPV vaccination is crucial to 
obtaining high vaccination rates and a reduced number of people affected by 
cervical cancer. Factors considered include physician recommendation, 
daughter’s age, knowledge of HPV and HPV vaccine, peer and media influence, 
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mistrust in pharmaceutical companies, religion, race, cost, and personal 
experience with STIs, abnormal pap smears, or cervical cancer.  Many studies 
have looked at factors that influence parents’ acceptability and decision to 
vaccinate their daughters, however little is known about their opinions on 
methods to improve HPV vaccination and completion. 
 The current study sought to explore parents’ opinions about the HPV 
vaccine and methods to improve vaccination rates depending on their daughters’ 
vaccination status. Specifically we explored (1) the causes of non-initiation and 
incompletion of the HPV vaccine and (2) opinions on possible means to improve 
vaccination initiation and completion. As of September 2012, 62 parents of girls 
between the ages of 11 and 17 years of age of the Pediatrics department of BMC 
were asked to participate in a short interview. After being initially approached and 
agreeing to participate, parents were read the informed consent form and a 
research assistant proceeded through the 20 minutes questionnaire. Parents 
were asked open-ended questions to determine their opinions on the HPV 
vaccine and their reasons for vaccinating or declining to vaccinate their daughter. 
Those who showed concerns about vaccination for their daughters 
mentioned their lack of knowledge on HPV and the vaccine, religious beliefs 
rendering the vaccine unnecessary, the relative newness of the vaccine, the 
number of doses in the series and needle-phobia as barriers. Additionally, almost 
a third of the parents whose daughters had not initiated vaccination had not been 
offered the vaccine by their physicians suggesting missed opportunities for 
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vaccination. Only one of the parents of girls with incomplete vaccinations was 
able to accurately state the accurate number of doses and the accurate timeline 
for vaccination, indicating that lack of understanding of the vaccine dosing and 
schedule was the most important reason for non-completion of the series among 
this group of parents. 
In our study we found that the overall knowledge of HPV, its health 
consequences, and the rationale for HPV vaccination was poor, suggesting the 
need to invest in education. This study also looked at means to improve 
vaccinations and how the parents felt about them. Nearly all parents believed 
clinic reminders would be helpful because it would allow them to prepare for the 
appointment and make sure they completed the doses on time. Participants were 
divided on mandating the HPV vaccine since while some felt it would improve 
vaccination rates other believed it should be the parents’ choice. Parents were 
also divided on making the HPV vaccine available at schools and against 
community site vaccinations (although some agreed pharmacies could be a 
possibility) and allowing adolescents to give their own consent about the HPV 
vaccine. It is important to note that parents of girls with incomplete vaccinations 
were more likely than others to support the different methods mentioned that 
sought to improve accessibility and flexibility of receiving the vaccine which 
suggest that failure to complete the series may be due to time conflicts on the 
part of parents or adolescents in many cases.  
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 1 
INTRODUCTION  
 
Background 
 Human Papillomavirus (HPV) is the most common sexually transmitted 
infection (STI) with approximately 79 million Americans currently infected and 14 
million people becoming infected every year (CDC, 2013).  
Over 100 different strains of HPV have been documented, 40 of which 
affect the anogenital region. These types are further divided into high-risk types 
and low-risk types. High-risk types of HPV are those that can lead to cervical and 
other cancers. The most prevalent high-risk strains of HPV are responsible for 
99% of cervical cancers, and types 16 and 18 are responsible for approximately 
70% (CDC, 2013). HPV can also cause cancers of the vulva, vagina, penis and 
anus. Low-risk types of HPV are those responsible for genital warts and types 6 
and 11 cause approximately 90% of genital warts (Thompson, 2007). 
 HPV is transmitted by skin-to-skin contact. Although it is generally 
transmitted through sexual intercourse, penetrative vaginal or anal intercourse is 
not necessary to become infected (CDC, 2013). Condoms can reduce the risk of 
infection by approximately 70% (ACIP, 2010). Most HPV infections are 
asymptomatic (CDC, 2013). Currently, no medical treatments exist to cure HPV. 
Most HPV infections clear within a year of infection, however those that do not 
may lead to cervical and other cancers (Thompson, 2007).  
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 About 33,300 HPV related cancers are diagnosed every year and affect 
more women than men (figure 1) (CDC, 2012). Most HPV cancers affect the 
cervix but oropharyngeal disease is rising in incidence and is expected to 
surpass cervical cancer as the leading HPV-related cancer in the U.S. by 2020 
(CDC, 2012).  
  
 
Human Papillomavirus Vaccine 
Figure 1. Incidence of HPV related cancer per year from 2004 to 2008 (CDC, 
2012). 
Incidences of HPV-related cancers also vary depending on race and 
ethnicity with the lowest rates reported in Asian and Pacific Islanders, the highest 
rates in Hispanics and Blacks (CDC, 2013). While cervical cancer is treatable if 
caught early, and the CDC (2013) emphasizes the importance of regular 
screenings and preventative measures in order to promote vaccine uptake and a 
decrease in the incidence of HPV related cancers.  
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Human Papillomavirus Vaccine 
 Two prophylactic HPV vaccines are currently Food and Drug 
Administration (FDA) approved and recommended by the Advisory Committee on 
Immunization Practices (ACIP): Gardasil and Cervarix. Gardasil, a quadrivalent 
prophylactic vaccine for types 6, 11, 16, and 18, was approved in 2006 
(Markowitz et al., 2007). In October 2009, Cervarix, a bivalent HPV vaccine for 
types 16 and 18, was approved (ACIP, 2010). Gardasil received a permissive 
recommendation for boys ages 9-26 in 2009, which was upgraded to a routine 
recommendation for boys 11-21 (with permissive remaining from 9-26) in 
October 2011 (FDA, 2010).  
Both vaccines are recommended for girl’s aged 11 or 12 years and catch-
up vaccination is advised for girls between the ages of 13 and 26 (ACIP, 2010; 
Markowitz et al., 2007).  This age was determined in order to vaccinate nearly all 
girls before their sexual debut and consequently reduce the rates of cervical 
cancers (Harper & Paavonen, 2008). This recommended age group was 
determined by two factors: 1) girls should be vaccinated before the onset of 
sexual activity in order to have maximum efficacy and studies have shown that 
by age 15, 24% of girls are sexually active, and 2) vaccination produces higher 
antibody titers found in younger compared with older adolescents (ACIP, 2010; 
Harper & Paavonen, 2008). Additionally, catch-up vaccination was recommended 
for girls between 13-26 since they represent the age group at which new HPV 
infection rates are most prevalent (ACIP, 2010; Markowitz et al., 2007). Offering 
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vaccination would protect those in that age group that have not initiated sexual 
activity or been infected with HPV strains covered in the vaccine (Harper & 
Paavonen, 2008). Another reason to vaccinate prior to age 13 is that more pre-
teens present for routine examinations (Vadaparampil et al., 2011).  
The vaccines are administered as a three dose series. The second dose 
should be administered 2 months after the first dose and the third six months 
after the initiation of the series (Thompson, 2007). Only 53% of girls eligible for 
the vaccine have been vaccinated and 37% of girls who initiate the series do not 
complete it (CDC, 2012). Additionally, vaccination rates are lower for girls of the 
recommended age than for older girls (CDC, 2012). Disparities in vaccination 
coverage also vary with girls of higher socioeconomic status being more likely to 
complete the series after initiation, even though initiation is higher for those 
bellow poverty level (CDC, 2012).  
 
Parental attitudes towards HPV vaccination  
 Adolescent girls are minors and consequently need their parent’s consent 
to get the vaccine. Understanding their opinions about HPV vaccination is 
therefore crucial to obtaining high vaccination rates and a reduced number of 
people affected by cervical cancer. Research has found that parents that support 
vaccination tend to justify their choice with their role as parents to protect their 
children against any diseases that can be prevented and consequently feel that 
the benefits outweigh the potential negatives of HPV vaccination. On the other 
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hand, some believe that other factors such as religious affiliation, possible links 
to early sexuality, accessibility and more, need to be taken into account in order 
for them to accept or refuse the HPV vaccine for their daughters (Perkins et al., 
2010).   
Studies have found that whether or not the adolescent’s medical provider 
gives a strong recommendation for the vaccine is the most important factor for 
vaccination (Perkins & Clark, 2012; Rosenthal et al., 2011; Vadaparampil et al., 
2011). Interestingly, physicians point out many of the same concerns about the 
HPV vaccine as parents.  Provider concerns could be a potential barrier to HPV 
vaccination since providers with concerns may offer only a weak 
recommendation (Perkins & Clark, 2012). Physicians have expressed difficulties 
bringing up the topic of HPV into their consultations, due to the sensitive nature 
of discussion sexually transmitted infections. Along the same lines, doctors were 
inclined to wait until the adolescent was older if they did not believe that the 
adolescent was sexually active.   Another barrier to vaccination is the lack of 
school entry mandates, which facilitate uptake.  Physicians also find it difficult to 
recommend the HPV vaccine to their patients since it is not mandated for school 
entry unlike other vaccines (Perkins & Clark, 2012; Huges et al., 2011).  This has 
lead researchers to think that new ways to discuss the HPV vaccine should be 
developed in order to improve vaccination rates (Huges et al., 2011).  
The adolescent girl’s age has positive and negative effects on the parent’s 
decision to vaccinate their daughter’s against HPV. Some parents believe that 
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the vaccination should be postponed until girls are older (Javanbakht et al., 
2012). Other studies showed increased acceptance of the vaccine and 
vaccination rates as their daughter’s became older (twelve and up) and a 
decrease after seventeen (Dempsey et al., 2006; Kessels et al., 2012). Delay of 
vaccination for some parents was associated with the idea that HPV vaccination 
was recommended only for girls who are currently sexually active, and thus felt 
that vaccinating their adolescents’ meant admitting their children were engaging 
in sexual intercourse (Hughes et al., 2011). Other parents believed that 
vaccination would promote earlier onset of sexual activity and this factor 
outweighs the future benefits the vaccine has to offer (Walhart, 2012).  Some 
parents and providers feel that the HPV vaccine also forces discussions of 
sexual topics with their children before they would like to or feel comfortable 
discussing them. This idea is linked to the idea that their daughters will engage 
earlier in sexual activity if the topic is discussed with them at an earlier date 
(Javanbakht, et al., 2012). Another limitation to HPV vaccination is linked to 
parents believing the vaccine will give girls a false sense of security that would 
encourage them to engage in unsafe sexual behavior and less frequent check 
ups (Mortensen, 2010; Perkins 2010). On the other hand, some parents believe 
that teen sexuality is inevitable and adolescents lack the maturity and judgment 
to make their own decisions about their health. Parents consequently see their 
role to protect them and feel that the vaccine is the best way to prevent future 
problems (Perkins et al., 2010).      
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Studies indicate a general lack of knowledge of HPV, the HPV vaccine, 
and the health consequences of the infection, but there is contradicting evidence 
on how lack of knowledge affects a parent’s decision to vaccinate their daughters 
(Walhart, 2012). Some studies have shown that knowledge is higher in parents of 
vaccinated girls while others found no difference in the amount of knowledge 
between vaccinators and non-vaccinators (Kessel et al., 2012; Perkins et al., 
2010).  Studies on the effects of knowledge have conflicting results.  One study 
demonstrated that parents’ opinions were confirmed rather than altered by 
receiving more information (Mortensen, 2010). Another study presented the idea 
that parents needed more information to commit to a decision, while some had 
vaccinated their children without receiving sufficient information, and confused 
HPV with other STIs (Allen et al., 2012). Lastly another study pointed out that 
parents appreciated getting more information since it reassured them in their 
decisions (Kennedy et al., 2011).    
Peers and the media can also influence parental decisions positively or 
negatively. When the media and the family have negative opinions about the 
HPV vaccine, parents associate the vaccine with more negatives and are more 
likely to refuse vaccination (Javanbakht et al., 2012). On the other hand, 
promotion of HPV vaccination by the peer group was associated with increased 
rates of vaccination (Dempsey et al., 2006; Kessels et al., 2012; Walhart, 2012). 
This is especially true for African American and Hispanic groups, communities in 
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which the peer group weighs importantly in the decisions made by the family unit 
(Allen et al., 2012).     
Mistrust in pharmaceutical companies also influences parents’ decisions 
to vaccinate their children. In one study, parents who had not previously heard of 
HPV were concerned that vaccination was primarily beneficial to pharmaceutical 
companies that could make more profits if higher coverage was achieved, rather 
than providing health benefits. This mistrust went as far as some parents 
comparing the push towards HPV vaccination to the Tuskegee experiment (Allen 
et al., 2012). Parents also expressed mistrust in pharmaceutical companies by 
stating that the drug was too new and that too little research had been conducted 
to fully understand the long-term side effects of the HPV vaccine. While it was a 
sufficient reason for some expressing this opinion to refuse vaccination, others 
saw it more as a reason to delay vaccination and use a “wait and see” approach 
to the situation (Hughes et al., 2011). Some providers echoed these concerns 
(Perkins, 2012).  The insecurity about the safety of the vaccine can also be linked 
to the fact that parents are for the most part unaware of the research that 
medication has to undergo to be approved for the public (Kennedy et al., 2011).       
Religion can also play a role in parents’ acceptance and decision of HPV 
vaccination.  Conservative religious values related to abstinence prior to 
marriage have been associated with lower rates of HPV vaccination among 
parents of Jewish background (Gordon, Waller, & Marlow, 2011), and Christian 
backgrounds except for Catholics (Shelton et al., 2011; Walhart, 2012).    
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 Research is inconclusive on the effects of race on HPV vaccine 
acceptance (Kessels et al., 2012). Some research has shown that there are 
lower rates of complete HPV vaccination in minority groups (Perkins et al. 2012). 
Other research found that African American women were more wary of the 
vaccine than other ethnic groups were (Walhart, 2012). Other research also 
looked at differences between African American parents and Haitian parents and 
found that Haitian women were less likely to vaccinate their daughters which 
points out that there can be differences within ethnic groups, which may have 
been linked to a provider issue (Iloka, 2008; Mercilus, 2009; Pierre Joseph et al., 
2012). In the Hispanic community, peer influence was shown to have strong 
effects on the decision to vaccinate adolescents. Most parents pointed out that 
their peers stated concerns about birth defects and reproductive health. This 
translated into the general view that benefits of the vaccine did not outweigh the 
risks (Allen et al., 2012; Javanbakht et al., 2012).    
The cost of the HPV vaccine has also been shown to be a barrier to 
parental acceptance and vaccination decision. Previous research found that 76% 
of parents were likely to vaccinate their daughter if the HPV vaccine were free as 
opposed to only 45% if they had to pay for the vaccine (Walhart, 2012). 
Additionally, most parents had the misconception that free vaccination programs 
such as the Vaccines for Children were only available for young childhood 
vaccines and did not include the HPV vaccine, or worse, did not know these 
programs existed which could further increase the barriers some may face when 
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it comes to vaccinating their children (Javanbakht et al., 2012). This is reinforced 
by the fact that lower rates of HPV vaccination completion are recorded for lower 
income women (CDC, 2012).     
Lastly, personal experience with STIs, abnormal pap smears, or cervical 
cancer, has shown to positively affect parental acceptance of the HPV vaccine 
(Mortensen, 2010; Dempsey et al., 2006). This was shown in a parent’s 
increased perceived risk and desire to protect their child. In some cases this led 
to parents requesting their daughter be vaccinated before it was offered to them 
(Walhart, 2012; Javanbakht, 2012). In others, parents may have used their own 
experience of HPV infection and genital warts as a stronger motivator for them to 
avoid social stigma associated with STIs for their children (Dempsey et al., 
2006).  
 
Possible methods to increase HPV vaccination 
Many studies have found that parental knowledge of HPV and the HPV 
vaccine is low, as discussed previously. While some believe that increased 
parental education would increase vaccination rates, the data on the subject 
does not always support this (Allen et al., 2012; Joseph et al., 2012; Kessels et 
al., 2012; Perkins et al., 2010; Walhart, 2012). Further studies should be done to 
examine the effects of knowledge on vaccination rates.  
As mentioned previously, doctor recommendation is the most important 
factor leading to receipt of the HPV vaccine.  This factor led some researchers to 
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examine the relationship between HPV vaccination rates and reminders from 
their clinic. They found that at the hospital where the conducted the study, most 
parents that receive phone calls that their daughters’ HPV vaccines were due 
appreciated receiving the call and the call prompted them to get more information 
about the vaccine which lead to more informed decision for the patients (Mayne 
et al., 2012). This evidence was supported in another study that suggested that 
higher rates of initiation and completion may be improved by patients receiving a 
letter or a call from the clinic (Perkins et al., 2012).  
Other means thought to increase HPV vaccination coverage include 
installing a school mandate, having school-based and community site based 
vaccination, and allowing adolescents to give their own consent for the vaccine. 
We will discuss these further in later in the discussion.  
 
International versus U.S. uptake of HPV vaccine 
 High vaccination rates are key to decreasing the current rates of cervical 
cancer. Rates of cervical cancer vary significantly between developed and 
developing countries, with developing countries showing much higher rates. On 
the other hand, delivery strategies can increase HPV vaccination coverage in 
developing countries and thus have the possibility of decreasing the widening 
gap. LaMontagne et al. (2011), found that by using school based vaccination 
programs; high rates of vaccination could be found in Peru, Uganda, Viet Nam 
and India. School based vaccinations seem to also be responsible for high HPV 
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vaccination coverage in Europe (figure 2), while other methods result in lower 
rates (Hopkins & Wood, 2013).  
 
Figure 2. HPV vaccination coverage in different countries (Kessels et al., 
2012).  
While support for HPV vaccination seems to be increasing in the United 
States (US), with parental acceptance of the vaccine varying between 74 to 89%, 
three-dose vaccination rates remain at a low 32% (Zimet et al., 2010; Kessels et 
al., 2012). Exploring providers’ and parents’ opinions on different implementation 
methods is consequently crucial. Since countries that achieved the most 
successful HPV vaccination rates most often use school-based vaccinations, 
researchers believe that implementing such a program in the US would improve 
coverage significantly and thus decrease the discrepancy between acceptance 
and actual vaccination (Zimet et al., 2010).  
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School Mandate of HPV vaccine 
Due to the nature of the HPV vaccine, controversy exists surrounding 
mandatory HPV vaccination. School vaccination mandates are decided on a 
state-by-state basis. Currently only Virginia and D.C. have passed requiring HPV 
vaccinations for school entry (NCSL, 2013).   
Opponents to mandatory vaccination cite interference with parental 
autonomy, the mode of transmission of HPV, the already filled vaccination 
schedule, unknown long-term side effects, unknown lifetime and possible need 
for booster shots, and the gender bias of the mandate as reasons it should not 
be required for school entry (Haber et al., 2007) Additionally, parents have also 
voiced concerns about mandating the HPV vaccine due to procedural differences 
with other vaccines. In a study conducted in Virginia shortly before the enactment 
of the mandate, researchers found that although parents intended or had 
vaccinated their daughter, they did not necessarily support the mandate because 
unlike other vaccines there was an “opt out” caveat to the mandate. Another 
important concern expressed was related to the perceived rapidity after which the 
FDA approved it that the mandate was discussed (Pitts and Tufts, 2012). Other 
studies have also found discrepancies between parental acceptance of the 
vaccine and concurrence with the mandate stemming from the reasons listed 
above (Perkins et al., 2010).  
Those in favor of mandating the HPV vaccine for school entry focus on the 
potential long-term benefits offered by the prophylactic vaccine. As mentioned 
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previously, HPV vaccination rates are low in the US. Increasing coverage has the 
potential to reduce rates of cervical and other cancers and thus be a 
breakthrough in health by decreasing the rates of several cancers and 
overcoming healthcare disparities (Haber et al., 2007). In the past, the addition of 
mandates for both the Varicella and the Hepatitis B vaccines have increased 
vaccine uptake and reduced health disparities (Davis & Gaglia, 2005; Morita, 
Ramirez & Trick, 2008).  
 
Adolescents giving their own consent for HPV vaccine 
Although some feel that HPV vaccination should be used as a tool to promote 
discussions about sexuality between parents and daughters, conversations 
related to sexual health remains a difficult topic for parents to discuss with their 
teens (McRee et al., 2012). Due to the difficulties some teens may find to 
approach their parents in order to seek medical health when related to sexual 
health, all states have laws (different for every state) permitting adolescents to 
seek medical treatment without their parent’s consent with certain status 
conditions that vary per state. Status conditions are circumstances in which 
minors may be able to consent for themselves. These usually include 
emancipated minors, married teens and parents (figure 3).  
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Figure 3. Minor’s capacity to consent to sexually transmitted infection 
services (Culp & Caucci, 2013). 
Additionally, 7 states (California, Iowa, Kansas, Montana, Nebraska, North 
Carolina, and South Dakota) allow adolescents to seek prophylactic services for 
STIs. Since the HPV vaccine would fall under that category, in those states 
adolescents could get vaccinated without input from their parents. Expanding 
these privileges to preventative sexual health could potentially increase 
vaccination rates by increasing the number of teens vaccinated prior to exposure, 
which could potentially reduce the number of people affected by cancers in the 
future (Culp & Caucci, 2013).   
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THE CURRENT STUDY  
 
 The HPV vaccine can prevent infection from types 6, 11, 16, and 18 and 
thus prevent about 70% of cervical cancers and 90% of genital warts, as well as 
impact rates of vaginal, vulvar, anal, penile, and oropharyngeal cancers.  Even 
though the vaccine has the potential to reduce the incidence of cervical and other 
cancers, rates in the US remain low and only half of those that start the series 
completes it. Many studies have looked at factors that influence parents’ 
acceptability and decision to vaccinate their daughters, however little is known 
about their opinions on methods to improve HPV vaccination and completion. 
 This study sought to explore parents’ opinions about the HPV vaccine and 
methods to improve vaccination rates depending on their daughters’ vaccination 
status at Boston Medical Center (BMC). Specifically we will explore (1) the 
causes of non-initiation and incompletion of the HPV vaccine and (2) opinions on 
possible means to improve vaccination initiation and completion.  
 These findings will help understand barriers to initiation and completion of 
the HPV vaccine series, as well as current factors and potential future systems 
changes that could facilitate vaccination.  
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METHODS 
  
The study sought to determine the different aspects of HPV vaccination 
that affect parents’ decisions to vaccinate their children. As of September 2012, 
parents of girls between the ages of 11 and 17 years of age of the Pediatrics 
department of BMC were asked to participate in a short interview. At the time this 
study was written, BMC was the only location where participants had been 
interviewed. Later, participants at three Harvard Vanguard locations will be 
interviewed in order to compare differences between public and private clinical 
settings. After being initially approached and agreeing to participate, parents 
were read the informed consent form and a research assistant proceeded 
through the 20 minutes questionnaire. Parents were asked open-ended 
questions to determine their opinions on the HPV vaccine and their reasons for 
vaccinating or declining to vaccinate their daughter. All the interviews were 
audio-recorded and later transcribed and coded using qualitative methods. The 
flyers and questionnaire used in this study were also translated into Haitian 
Creole and Spanish in order to recruit non-English speakers to the study. 
Bilingual researchers performed and translated interviews in Haitian Creole and 
Spanish verbatim. All parents received a 20 dollars gift card as an incentive for 
their participation. The Institutional Review Board (IRB) at BMC approved the 
study.   
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Study Participants 
Parents that appeared to be accompanying girls between the ages of 11 
and 17 years of age were approached and asked about their interest in 
participating in the study. They were then asked questions to determine if they 
met the eligibility requirements.  To meet the study’s requirements participants 
must have had a daughter between the ages of 11 and 17, be their parent or 
legal guardian, be the person who allowed medical providers to give them 
vaccines, speak English, Haitian Creole or Spanish and be Caucasian, African 
American/Black or Hispanic/Latino. After completion of the interview, participants 
were asked to answer demographic questions. Prior to beginning the study, the 
researchers aimed to recruit participants according to predetermined categories 
(table 1).  
Table 1. Proposed Categories of Recruitment. 
Vaccination status Boston Medical Center 
Not initiated Black (n=8) White (n=8) Hispanic (n=8) 
Incomplete Black (n=8) White (n=8) Hispanic (n=8) 
Complete Black (n=4) White (n=4) Hispanic (n=4) 
 
Interview Questions 
 Four different versions of the qualitative questionnaires were used to 
conduct the interviews: not initiated, incomplete, complete and unsure. The 
questionnaire used for the interview depended on the parent/guardian’s 
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recollection of their daughter’s HPV vaccination status. When the parent/legal 
guardian said that their daughter received 0 shots, the researcher used the not 
initiated questionnaire. When the parent/legal guardian said that their daughter 
received 1 or 2 shots, the researcher used the incomplete questionnaire. When 
the parent/legal guardian said that their daughter received 3 shots, the 
researcher used the complete questionnaire. Lastly, when the parent was unsure 
of the number of shots their daughter had received, the researcher used the 
unsure questionnaire.  
 While some of the questions were altered to fit the adolescent’s 
vaccination status, nine general categories of questions were asked to all 
participants. General categories asked to all participants were (1) knowledge of 
HPV and the HPV vaccine, (2) vaccination decision, (3) Doctor’s discussion of 
vaccine, (4) effects of religious frame and HPV being an STI, (5) parental 
experience with abnormal pap smears, genital warts, and cervical cancer, (6) 
ideas to improve vaccination initiation and completion, (7) HPV age mandate, (8) 
school and community site based vaccinations, and (9) adolescents giving their 
own consent for vaccination.  
 During the course of the study we modified questions so that participants 
had a better understanding of what they were being asked. Questions were also 
added in order to obtain a more rounded understanding of all the participants’ 
beliefs and address emerging themes. Specifically, we added two questions on 
whether parents would agree with adolescents being able to give their own 
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consent for vaccination and at what age they would be comfortable with letting 
them make such a decision. 
 The first few questions of each questionnaire sought to determine the level 
of knowledge about HPV and the HPV vaccine the participants had. Those who 
revealed no knowledge of the topic were introduced to HPV by being read a short 
informational blurb:    
“Let me tell you a little bit about HPV so that you know more about what we are 
talking about in the interview. HPV is a virus.  HPV is spread from one person to 
another by contact with the skin of the vagina or penis.  People usually catch 
HPV from having sex, but they can catch it from touching someone else’s 
genitals, even if they do not have sex.  Condoms can decrease the chance that a 
person catches HPV, but they are not 100% effective. The HPV vaccine prevents 
the most dangerous kinds of HPV. HPV can’t be cured with antibiotics because it 
is a virus.  Sometimes after someone catches HPV, it never goes away.  If this 
happens, it can cause problems.  HPV can cause abnormal PAP smears, warts 
on the penis or vagina, and later in a person’s life, cancer of the cervix (uterus or 
womb), anus, and mouth.” 
The purpose of the information was to give parents some background knowledge 
with which to formulate their opinions. 
 The demographics section of the interview was performed after all 
questions were discussed with the parents so that they would feel more 
comfortable with the researcher. The data collected included race, age, gender, 
relationship to the adolescent girl, marital status, education, preferred language, 
country of origin, years in the US (for those born outside the US), expressed 
religious affiliation, religious attendance, number of people in household, 
household income and type of insurance.  
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Data Analysis 
Due to the qualitative nature of the study, codes were generated from 
interviews transcribed verbatim. Once interviews were transcribed, researchers 
met on a weekly basis to discuss codes for all the questions that the participants 
were asked in order to ensure that all agreed upon the generated codes. The 
generated codes were then grouped into general categories and themes. 
After the interview, researchers reviewed the adolescent’s immunization records 
using BMC’s logician, an electronic health record system, to retrieve the dates of 
any HPV vaccine injections that the adolescent girls received. These records 
were also used to see whether parent’s recall of HPV vaccination matched actual 
HPV vaccination.  
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RESULTS 
 
Recruitment Sample 
 In our recruitment process, researchers approached 402 patients that 
appeared to fit the eligibility requirements. Out of those approached, 222 patients 
were ineligible and 111 declined. The main reasons for declining to participate in 
the study were a lack of interest and time constraints. In the recruitment of 
participants, researchers sought to follow the predetermined number of people 
per category. However, due to some parents’ inaccurate report of the number of 
shots their daughter had received some categories were over-recruited (table 2).   
Table 2. Actual Categories of Recruitment. 
Vaccination 
Status 
Boston Medical Center 
Not initiated Black (n=11) White (n=7) Hispanic (n=6) Other* (n=1) 
Incomplete Black (n=9) White (n=3) Hispanic (n=3) Other (n=1) 
Complete Black (n=11) White (n=5) Hispanic (n=4) Other (n=1) 
 
Demographics  
 To date 62 parents completed interviews. Information was organized 
according to their daughter’s vaccination status (table 3). The parent’s mean age 
was 44.2 and their daughters’ mean age was 14.0. The average age of girls with 
0, 1-2, and 3 HPV vaccine shots were 14, 13.6, and 14.4 respectively. 
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Table 3. Demographic Information 
Mean (range) or (%) 
Not 
started Incomplete Complete Total 
P 
value  Variable 
25 (40.3) 17 (27.4) 20 (32.3)* 62 (100)  
Race     .992 
African American 11 (44.0) 9 (52.9) 10 (50.0) 30 (48.4)  
Caucasian 6 (24.0) 3 (17.6) 5 (25.0) 14 (22.6)  
Hispanic 7 (28.0) 4 (23.6) 4 (20.0) 15 (24.2)  
Other  1 (4.0) 1 (5.9) 1 (5.0) 3 (4.8)  
Age (years) 41.2 
(26-51) 
44.3 
(30-65) 
44.9 
(30-64) 
44.2 
(26-65) 
.337 
Gender     .478 
Female 23 (92.0) 14 (82.4) 16 (80.0) 53 (85.5)  
Male 2 (8.0) 3 (17.6) 4 (20.0) 9 (14.5)  
Relationship to 
teenage girl     
.731 
Mother  21 (84.0) 13 (76.5) 14 (70.0) 48 (77.4)  
Father 2 (8.0) 3 (17.6) 3 (15.0) 8 (12.9)  
Guardian 2 (8.0) 1 (5.9) 3 (15.0) 6 (9.7)  
Age of adolescent girl 14  
(11-17) 
13.6  
(11-17) 
14.4  
(11-17) 
14  
(11-17) 
.567 
Marital status     .786 
Single  9 (36.0) 5 (29.4) 4 (20.0) 18 (29.0)  
Married 9 (36.0) 7 (41.2) 11 (55.0) 27 (43.5)  
Divorced/widowed/ 
separated 6 (24.0) 3 (17.6) 4 (20.0) 13 (21.0) 
 
Non-marriage 
partnership 1 (4.0) 2 (11.7) 1 (5.0) 4 (6.5) 
 
Education     .523 
Less than high school  2 (8.0) 2 (11.7) 2 (10.0) 6 (9.7)  
Completed high 
school 8 (32.0) 8 (47.1) 11 (55.0) 27 (43.5) 
 
More than high 
school 15 (60.0) 7 (41.2) 7 (35.0) 29 (46.8) 
 
Preferred language     .372 
English  19 (76.0) 13 (76.5) 18 (90.0) 50 (80.6)  
Haitian Creole 3 (12.0) 0 (0) 0 (0) 3 (4.8)  
Spanish  2 (8.0) 3 (17.6) 1 (5.0) 6 (9.7)  
Other 1 (4.0) 1 (5.9) 1 (5.0) 3 (4.8)  
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Table 3. Demographic information continued 
Mean (range) or (%) 
Not 
started Incomplete Complete Total 
P 
value  Variable 
25 (40.3) 17 (27.4) 20 (32.3)* 62 (100)  
Country of origin      .599 
United States 13 (52.0) 11 (64.7) 13 (65.0) 37 (59.7)  
Other 12 (48.0) 6 (35.3) 7 (35.0) 25 (40.3)  
Years in the US  
(for those born in 
other countries) 
 
18.5  
(1-42) 
17.3  
(7-29) 
25.4  
(11-42) 
18.7  
(1-42) 
.384 
Religious affiliation     .547 
Yes  16 (64.0) 8 (47.1) 11 (55.0) 38 (61.3)  
No  9 (36.0) 9 (52.9) 9 (45.0) 24 (38.7)  
Religious 
attendance     
.625 
> once /week 7 (28.0) 2 (11.8) 4 (20.0) 12 (20.7)  
1-3 times /month 8 (32.0) 5 (29.3) 4 (20.0) 15 (25.9)  
2-3 times /year 3 (12.0) 2 (11.8) 5 (25.0) 10 (17.2)  
Never 7 (28.0) 8 (47.1)  7 (35.0) 21 (36.2)  
Number of people in 
household 3.9 (2-7) 4.4 (2-7) 4.1 (2-8) 4.1 (2-8) 
.624 
Household income     .595 
<20,000 12 (48.0) 7 (41.2) 7 (35.0) 26 (41.9)  
21,000-40,000 5 (20.0) 6 (35.3) 6 (30.0) 17 (27.4)  
41,000-60,000 3 (12.0) 4 (23.5) 2 (10.0) 9 (14.5)  
61,000-80,000 2 (8.0) 0 (0) 3 (15.0) 5 (8.1)  
81,000-100,000 1 (0) 0 (0) 0 (0) 1 (1.6)  
>100,000 2 (8.0) 0 (0) 2 (10.0) 4 (6.5)  
Type of insurance      .703 
Private  6 (24.0) 4 (23.5) 5 (25.0) 15 (24.2)  
Public 19 (76.0) 13 (76.5)  14 (70.0) 46 (74.2)  
None 0 (0) 0 (0) 1 (5.0) 1 (1.6)   
*Two records could not be found so are only based on parent’s report 
Knowledge of HPV and the HPV vaccine 
 Over 80% of the participants had heard of HPV prior to their interview, 
however most were familiar with the term but did not have any knowledge of the 
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virus, the health problems it causes or how it is transmitted. All participants 
generally only knew that the virus caused cervical cancer, and that cervical 
cancer could be fatal, and most parents also knew that HPV is a STI.  A limited 
number of parents had heard that HPV causes genital warts, infertility (usually 
referring to hysterectomy for cervical cancer), abnormal Pap smears, oral and 
anal cancer. 
Seventy-six percent of parents had heard of the HPV vaccine either from 
the media, their peers or their doctors, and 41.3% knew it prevented cervical 
cancer. Most parents had been exposed by the media to the HPV vaccine 
through TV commercials, however a few parents reported negative media 
exposure regarding side effects of the vaccine. Over 75% of participants reported 
no peer communication regarding the vaccine. When parents had talked to their 
friends about the HPV vaccine, half felt that the peer influence promoted 
vaccination, while the remainder felt that their peers discouraged vaccination due 
to concerns about the side effects and the newness of the vaccine. However, 
most participants (71.7%) were unaware whether or not their friend’s daughters 
were vaccinated or not.  
Participants also showed low concordance between parents’ recall of the number 
of vaccine doses the daughter had received and the number of doses recorded in 
the electronic medical record (table 4).  Parents of girls with non-initiated and 
incomplete series were more likely to be correct about their daughter’s 
vaccination status then parents of girls who had completed the series (p=0.041). 
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Table 4. Parental report versus EMR dates 
Concordance 
(%) 
Not initiated Incomplete Complete All P value 
Yes 16 (64.0) 11 (64.7) 6 (30.0) 33 (53.2) 
No 9 (36.0) 6 (35.3) 14 (70.0) 29 (46.8) 
P= 0.041 
 
Parents were also questioned on their knowledge of side effects 
associated with the vaccine. Many of the participants had not heard of side 
effects or could not recall what they were. Side effects that were mentioned 
included painful at the injection site, increased libido, headache, neurological 
disorders, paralysis, numbness of limbs, swelling of tongue, skin rash and 
menstrual changes.  
 
Vaccination decision 
All parents reported that their girls had received vaccines in the past. 
There was an overall consensus that vaccines were good for health. However, 
about 15% of them refused vaccines (HPV and flu shots) in the past when their 
doctor recommended it. Parents mentioned side effects, peer and media 
influence as key factors in their refusal.  
 The age at which parents believed girls and boys should be vaccinated did 
not vary much between the different groups (table 5). The age parents thought 
boys should be vaccinated was slightly lower than girls because parents believed 
boys where more sexually active than girls and had an earlier sexual debut 
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(P<0.05). Most parents felt vaccination should occur at the age recommended by 
physicians and/or prior to sexual debut/curiosity. Some of these parents did show 
concerns about the age of HPV vaccination mentioning that they feared the 
vaccine may encourage promiscuity and that the consequences of sex extend 
beyond the HPV vaccine.  
Table 5. Age at which parents believe vaccination should occur 
Age 
(years) 
Non-
initiated 
Incomplete Complete Total P value 
Girls 14.2 11.6 13.1 13.4 
Boys 12.9 11 12.7 12.5 
P < 0.05 
  
Several arguments emerged in the parents’ decisions to vaccinate their 
daughters against HPV. The main reason parents stated was centered on the 
benefits the vaccine offered and that vaccines were good for people’s health in 
general. Parents mentioned a “better safe than sorry” approach, expressed the 
desire to prevent cervical cancer, especially since some had the misconception 
that cervical cancer was hereditary disease, and several simply stated that they 
trusted their physician’s recommendations for all vaccines. A second important 
factor was parents wanting to protect their children, either because they believed 
their control over their children’s sexual behavior was limited and that all young 
adults would eventually become sexually active or because they felt that 
vaccination fell within the parental responsibility to protect their children.  
 28 
Those who showed concerns about vaccination for their daughters 
mentioned their lack of knowledge on HPV and the vaccine, religious beliefs 
rendering the vaccine unnecessary, the relative newness of the vaccine, the 
number of doses in the series and needle-phobia as barriers. These opinions 
were mostly expressed by parents of girls with non-initiated HPV vaccinations, 
and were rarely presented as barriers to completion. Some parents of girls with 
incomplete and completed vaccinations also mentioned these concerns, however 
in those cases their perceptions of potential benefits outweighed their concerns. 
Additionally, almost a third of the parents whose daughters had not initiated 
vaccination had not been offered the vaccine by their physicians.  In 2 of these 7 
cases, girls had been previously ineligible due to young age or living outside the 
US, suggesting that in the other cases physicians missed opportunities to offer 
the vaccine.  
Parents of daughters with incomplete vaccinations were asked additional 
questions in order to better understand why they did not complete the HPV 
vaccine series. Only one of these parents was able to accurately state the 
accurate number of doses and the accurate timeline for vaccination, indicating 
that lack of understanding of the vaccine dosing and schedule was the most 
important reason for non-completion of the series among this group of parents. 
Almost all these parents mentioned the vaccine being a series as a barrier to 
completion. Most of them stated that it was easy to make, cancel, reschedule or 
come to appointments. None of the participants had co-pays or other cost 
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barriers to vaccination. Lastly none of the parents stated changing their minds 
after the first injection but one parent pointed out they were waiting for the yearly 
physical to get subsequent doses of the vaccine.  
In over 70% of cases mothers made the decision to vaccinate or not their 
daughters alone. Some of these mothers mentioned having the doctor as a 
deciding factor in their decision. Other mothers mentioned overriding their 
daughter’s opinions on vaccination, especially when the daughters’ reasons for 
not wanting to take the vaccine related to dislike of needles. In other cases both 
parents were included and some families included their daughters into the 
decision. Two parents mentioned a family discussion; one resulted in positive 
influence while the other was negative.  
 
Physician influence 
 Nearly all parents reported that their physician presented the vaccine as 
important. A few mentioned that their doctors encouraged them to vaccinate 
while explicitly stating that vaccination was the parents’ choice, and others stated 
that their doctors normalized the vaccine, presenting HPV as one of several 
routine, recommended vaccinations. Parent’s recall of their conversations prior to 
vaccination included discussion of the vaccine in the context of sexuality and how 
it should be administered prior to sexual debut, the number of vaccines required 
to complete the series, the importance of preventing cancer, and that prevention 
is better than treatment. However parents showed limited recall of these 
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conversations, which declined with the time elapsed since the initial 
conversation. 
 Almost half of the participants did not feel the physicians provided 
adequate information to them about the vaccine. They mentioned that concerns 
about side effects were not appropriately addressed or that new vaccines 
warranted more discussion than older vaccines. More parents of non-initiated 
vaccination girls and completed vaccination girls had negative impressions of 
their conversations with their physician than parents of girls with incomplete 
vaccinations (37.5%, 54.5% and 20% respectively).  Two of the parents had 
predetermined opinions of the vaccine and pointed out that the physician’s 
response was to give a pamphlet with information on the vaccine rather than 
discuss it further.  
 
Religious frame and concerns about STI 
 Most parents (87%) claimed that religion did not play a role in making their 
decision whether to vaccinate of not their daughters, even though 61.3% of 
parents expressed religious affiliations. Those who did mention religion as a 
barrier to vaccination stated that their belief in abstinence made the vaccine 
unnecessary. One father mentioned healing through prayer to be more beneficial 
then traditional practices and another father mentioned that while he was for HPV 
vaccination, religious beliefs had been a barrier for his ex-wife, which delayed 
their daughter’s completion of the vaccination series.  
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 Parents also explicitly denied concerns about vaccinating their daughters 
against an STI. In fact, many parents mentioned HPV vaccination as a way to 
protect their daughters against potential negative consequences of sexual activity 
and believed that vaccination was consistent with good parenting practices. 
Opponents mentioned that vaccinating girls against an STI stigmatized them or 
that it did not match their religious beliefs. 
 
Personal experiences with abnormal pap smears, genital warts and cervical 
cancer  
 Many parents expressed prior personal experience with abnormal pap 
smears, genital warts and cervical cancer (table 6). Moreover, four parents 
mentioned that a family member or friend had died of cervical cancer. Two of 
them had daughters with non-initiated HPV vaccinations, one with incomplete 
HPV vaccination and one with complete HPV vaccination. . The first parent with 
personal experience with cervical cancer that had not yet vaccinated her 
daughter against HPV had previously lived outside the US but intended to 
vaccinate her daughter. The other parent of non-initiated daughter stated that her 
lack of knowledge of the disease and uncertainty of efficacy of the vaccine were 
the major barrier preventing her acceptance of the HPV vaccine for her daughter.  
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Table 6. Percentage of parents with personal experiences with abnormal 
pap smears, genital warts and cervical cancer 
 Daughter vaccination status 
Prior 
Experience  
n (%) 
Not initiated Incomplete Complete P value 
Abnormal Pap 
smear 
15 (65.2) 3 (42.9) 4 (28.6) P= 0.089 
Genital warts  6 (26.1) 0 (0) 2 (14.3) P= 0.264 
Cervical cancer  10 (41.7) 2 (28.6) 1 (8.3) P= 0.077 
 
Parents also had different views about the seriousness of abnormal pap 
smears, genital warts and cervical cancer. Most parents felt that all three 
diseases were serious conditions, however opinions ranged from them not being 
serious to no knowledge, to uncertain, to somewhat serious.  Abnormal pap 
smears were perceived to be a serious problem because they indicated serious 
consequences and expressed a general fear of cancer. They also related them to 
being more of an issue for promiscuous women. Some participants did mention 
that their fear was reduced by the knowledge of the possibility of false positives 
and an overall trust in their physician. Three main themes emerged in 
participants’ view of genital warts as a serious problem: genital warts are a taboo 
topic, non-fatal STIs impair quality of life, and limited or no knowledge of genital 
warts. Cervical cancer was considered a serious problem by parents because it 
could result in infertility and could be fatal. Additional factors considered in the 
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seriousness of cervical cancer revolved around the misconception that cervical 
cancer was hereditary, and common. Additionally a few parents knew that 
cervical cancer was a result of HPV, an STI, and believed that only promiscuous 
women would be subject to it.  
Parents expressed different views on their daughter’s future risk for 
abnormal pap smears and how the vaccine affects this risk. Parents of girls with 
non-initiated and incomplete HPV vaccinations perceived risk for an abnormal 
pap smear to be in general much greater than mothers of daughters with 
complete vaccination status. The main reason participants named for their 
daughters being at high risk for abnormal pap smears was family history of 
abnormal pap smears. Those that viewed their daughters as having a moderate 
risk for abnormal pap smears pointed out that all women were at risk and their 
daughter was no exception. Lastly parents that viewed their daughters as being 
low risk talked about how their risk was modified by the vaccine, regular check-
ups, safe sex practices (or abstinence), parenting and their daughter’s age.  
Parents’ perceptions of their daughters’ susceptibility to genital warts in 
the future varied greatly. Additionally, about half of the parents were unaware 
that HPV was associated with genital warts or that the HPV vaccine could 
prevent 90% of genital warts. Thus those participants did not believe their 
daughter’s risk for genital warts to be modified by vaccination. Parents’ also 
expressed limitations of their control over their children’s behavior and safe sex 
practices as factors influencing their perception of the vaccine’s protective 
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qualities against genital warts. It is also important to note that some (4) parents 
confused genital warts with herpes and others (2) confused HPV with human 
Immunodeficiency Virus (HIV), reinforcing the point that participants had limited 
or no knowledge of genital warts and the HPV virus.   
Parents were divided on whether or not their daughter’s were at risk for 
cervical cancer. About half mention that all women were at risk for cervical 
cancer or that family history of cancer increased their daughter’s chance of 
getting cervical cancer. The others felt their daughter’s risk was lowered by 
abstinence, safe sex practices and regular checkups or by giving their daughter 
the vaccine. Overall, nearly all parents, even those who declined to vaccinate 
their daughters, pointed out that they believed the HPV vaccine could offer some 
to full protection against cervical cancer. 
 
Means to improve vaccination  
 Nearly all parents responded that public education would be personally 
helpful for initiation and completion of the HPV vaccine. The few who did not 
agree preferred to do their own research or favored their physicians as the 
source of information on the vaccine.  
 More than 90% of parents found that reminders from the clinic (letter, 
phone call, email, text messages) would be helpful to them. Moreover, 64.3% of 
parents expressed that they preferred receiving email since they used it more 
than other means of communication and was less invasive (table 7).  
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Table 7. Preferred method of communication 
Method Phone call Letter Email 
Text 
Message 
Percentage  
n (%) 
6 (42.9) 6 (42.9) 10 (64.3) 8 (57.1) 
 
 Parents also offered their own ideas to improve initiation and completion 
of the vaccine series. Some parents talked about “sex ed” classes in school, peer 
educators and community site based education to improve information of the 
virus and the vaccine in the adolescent population. Another popular request from 
parents was to receive more information from the clinic and physicians in the 
form of flyers, pamphlets and doctor-parent talks. Less frequent suggestions 
included more flexibility in appointment scheduling, use of social network sites 
and monetary compensation for the adolescents. 
 
HPV vaccine school mandate 
  A majority of parents (65.2%) approved requiring HPV vaccination for 
school entry and two parents gave a conditional approval of the vaccine 
depending on safety and girls’ age. Of note, all parents of girls with incomplete 
HPV vaccinations were for the mandate. Parents who favored the mandate 
explained it would improve girls’ health in the population, it normalized the 
vaccine, reduced stigma associated with the vaccine and protected girls from 
infection. On the other hand, parents against the vaccine felt the mode of 
 36 
transmission did not justify mandating the vaccine, felt that mandates 
disregarded parental opinions and were concerned about the side effects.  
 
Opinions on offering HPV vaccination at schools and community sites  
 Parents of non-initiated and completely vaccinated daughters had 
contradicting opinions on whether or not they were for or against providing 
vaccines at schools (50.0% and 42.9% for school vaccination). Parents of 
daughters with incomplete vaccinations however all favored school based 
vaccinations, perhaps indicating that difficulty with coming to clinic contributed to 
series non-completion. Reasons parents opposed school-based vaccinations 
included lack of hygiene and safety at school, parents preferred the physician 
because they trust and are more familiar with their patients, belief that school is 
not a place for health concerns, lack of privacy, belief that the school nurse is not 
competent, desire to receive all three shots at the same facility, and the beliefs 
that new vaccines warrant more physician discussion, there is a lack of medical 
expertise in school and it should be a parent’s decision not the school’s decision. 
Those that favored school-based vaccinations mentioned convenience, improved 
access and competent school nurses as reasons for their approval.  
 Parents were also asked if they would they vaccinate their own children at 
school if the vaccine were available. Once again, parents of daughters who had 
not initiated the series and parents of daughters who had completed the series 
had contradicting opinions with a slight majority of them opposed to vaccinating 
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their own child at school (50.0% and 57.1% respectively). Three fourths of 
Parents of daughters with incomplete vaccination series were in favor of getting 
their daughters vaccinated at school.  
 Most parents (71.1%) were uncomfortable with providing HPV vaccination 
at community sites such as pharmacies, churches, YMCAs.  However, parents of 
girls with incomplete vaccinations were divided on the issue. This topic also 
raised the issue that some parents would be open to community site vaccination 
for the population at large to improve access for girls without regular physicians 
but were uncomfortable with having their own children vaccinated there. Other 
parents mentioned that only pharmacies were an option versus all the other sites 
mentioned because they felt that the level of medical expertise was higher. 
Lastly, some parents pointed out that churches would not be a proper place for 
vaccination since it was a place of spirituality and promoted abstinence, while 
others felt that the high level of trust in the church felt by congregants would 
facilitate uptake.  
 
Adolescent consent  
 Since this question was added later into the study, not all parents were 
asked whether or not they supported adolescents giving their own consent about 
initiating and completing the HPV vaccine series. Of those who were asked 
(n=11), half of the parents agreed with them giving their own consent at a median 
of 15 years of age. One parent did raise the issue that they agreed that 
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adolescents in general should be able to make their own decision about the 
vaccine but did not feel comfortable with her daughter making her own decision 
because she wanted to be involved in the decision making. 
 
Table 8. Selected quotes. 
 Facilitates vaccination  Impedes vaccination 
Health beliefs  Vaccine protects 
daughter/prevents cancer 
 “I’d never want wake up one 
day and she has cervical 
cancer and I had the 
opportunity to prevent or slow 
it down or whatever” 
 
“I think if it’s a vaccine that’s 
going to protect them from 
any kind of cancer. Any 
vaccine that would help with 
that would be a good idea.” 
 
Vaccine is for sexually active 
girls 
“Especially if she’s not doing 
anything. It’s like blaming a 
kid before they even get a 
chance to do anything, you 
know what I’m saying?” 
 
 
Cues to action 
 
Strong physician 
recommendation 
“Let’s say, she didn’t force 
me. But she explained to me 
the benefits. And then, in 
order for me to make the right 
decision about it. Not really to 
force me to do it. But just as 
any other medical treatment, 
the doctor cannot force you, 
you know. The doctor just tell 
you exactly what is good for 
your kid or not” 
 
Negative peer influence 
“She always talking about 
they try to use you as a 
guinea pig to see if vaccine 
work on humans or whatever, 
so she said she didn’t want 
them using their daughter to 
try the stuff on her.” 
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Table 8. Selected quotes continued.  
Perception of 
HPV 
 
Extension of parental control  
“Parents, as much as they 
love their children as much as 
they do, their children are 
going to do what they’re 
going to do” 
 
Fear of cancer 
“When you see the “big c” ... 
cancer… it’s a scary word”  
 
 
Newness of vaccine 
“Like if you remember the 
varicella, it was kind of, in the 
beginning, people didn’t really 
want to get it because it felt 
like, ok, if I get the varicella, 
ok, I don’t get chicken pox, 
and then all of a sudden 
there’s a chance that as an 
adult I can get chicken pox 
and then get the shingles and 
end up dying. You know what 
I mean? So I think that’s what 
happens with all them 
vaccines. People, it’s that first 
initial scare factor, and then 
once, you know, they start to 
see that’s its more effective 
and that its working, you 
know, people start and 
understand the issues and the 
things behind it, then I think it 
becomes good”  
 
Logistics 
 
Parental responsibility  
“I think it’s a parent’s 
responsibility to make sure a 
child gets all three.”   
 
 Lack of clinic reminders 
“They should have scheduled 
it I guess, they should have 
told me to schedule it” 
Means to improve vaccination 
 
“You just have to tell them the importance of it if they do decide it. So you know 
it’s really important. This is like baking a cake, you have to use all the ingredients 
or it doesn’t help. You have to break it down to basics. Cause you have to talk to 
people on a basic level”  
 
“Letter I really don’t read. Yeah if it’s not a bill I don’t even open it, you know. But 
if email, they always pop up and they always stay there.” 
 
“Either we text or email right now so that would smart.” 
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Table 8. Selected quotes continued. 
HPV vaccine school mandate 
“Like I tell you before and I tell you again; I recommend it and I think they should 
do it and force it cause there’s a lot of teenagers that are too sexually active, 
they’re too sexually active.” 
“Oh um I could see high school um definitely not middle school Probe: and why 
do you feel this way? I just think it’s too young to bring up those kinds of 
subjects” 
“That’s my right, my freedom. No, I mean it’s like telling me that my child has to 
have the shot before she can get an education. No. That’s the problem, This is 
my household, when the government gets into your household, when the school 
system gets into your household, no. I’m raising my child you’re not raising my 
child, it’s my decision, that’s, that’s my rights to decide on what I want to do with 
my child, and for them to hold back education because a child didn’t get 
vaccinated then excuse my language a lot fo dumb people in this universe” 
 
School and community site based vaccination  
 
“It just seems to me if you’re going to puncture somebody’s skin you should be 
doing it in a fairly sterile clean environment and schools and boys and girls clubs 
and places like that often are not all that clean” 
 
“I think a lot of parents might see it along the same lines as offering condoms in 
schools and that always causes a lot of controversy when schools choose to do 
it” 
 
“But for people who can’t make their appointments on time, you know, school’s 
the perfect place. The kids are already there.  Today’s a good day for you to 
have your shot. You can’t be late—you’re there already” 
 
Adolescent consent 
 
“Um I think that for some teens it could be appropriate um for the same reason I 
think that its appropriate in some cases for teens to make their own decisions 
about birth control. Because if there is a parental resistance to the idea but the 
teen feels that its something they need they should have that option” 
 
“Yea I mean once she’s 18 she can take her decisions but meanwhile I’m the one 
that takes decisions for her” 
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DISCUSSION 
  
Guidelines recommend that girls receive the HPV vaccine between their 
eleventh and twelfth birthday with catch-up vaccination for older girls, however 
rates in the US continue to be low (Zimet et al., 2010; Kessels et al., 2012). 
Researchers have suggested developing more methods to improve coverage but 
in order for them to be successfully implemented, these methods have to be 
acceptable to parents.  
In our study we found that the overall knowledge of HPV, its health 
consequences, and the rationale for HPV vaccination was poor, suggesting the 
need to invest in education. In fact, the primary reason that patients had not 
completed the series was lack of awareness of the number of doses and the 
timeline.  In addition, the most common concerns expressed by parents related 
to side effects and safety, which impacted primarily initiation and in a few cases 
completion of the series. The importance of knowledge in going from acceptance 
to actual vaccination was also observed in the fact that nearly all parents felt 
public education would be helpful. Participants who had not initiated the vaccine 
series also had very limited knowledge of the vaccine. This was explained in part 
because almost a third of the participants in this category had not been offered 
the vaccine at the time of the interview; we found many missed opportunities on 
behalf of the physicians to discuss the vaccine with their patients. Parents who 
decided to initiate and complete HPV vaccination for their daughter mainly talked 
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about their desire to protect them from cervical cancer. These participants were 
also more likely to know the number of doses needed for complete vaccination 
than parents of daughters with incomplete HPV vaccination although some 
mentioned the number of shots in the series rendered completion difficult. 
Similarly to previous studies, the parents we interviewed found physician’s 
influence critical to their decision to vaccinate their daughters. In addition most 
parents felt comfortable with vaccinating their child against an STI and their 
religions did not affect their vaccination decision. Unlike previous studies 
however, parents of girls with completed vaccination statuses had less 
experiences with abnormal pap smears, genital warts and cervical cancer than 
parents of girls with non-initiated and incomplete HPV vaccinations.  
This study also looked at means to improve vaccinations and how the 
parents felt about them. Similar to previous studies (Mayne et al., 2012), nearly 
all parents believed clinic reminders would be helpful because it would allow 
them to prepare for the appointment and make sure they completed the doses on 
time. Participants were divided on mandating the HPV vaccine since while some 
felt it would improve vaccination rates other believed it should be the parents’ 
choice. Parents were also divided on making the HPV vaccine available at 
schools and against community site vaccinations (although some agreed 
pharmacies could be a possibility) and allowing adolescents to give their own 
consent about the HPV vaccine. It is important to note that parents of girls with 
incomplete vaccinations were more likely than others to support the different 
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methods mentioned that sought to improve accessibility and flexibility of receiving 
the vaccine which suggest that failure to complete the series may be due to time 
conflicts on the part of parents or adolescents in many cases.  
Several limitations should be considered when reviewing the results of this 
study. The study sample included a small number of participants and was 
recruited from an urban academic medical center serving primarily low-income 
and minority patients, which may restrict the applicability of our results to the 
population at large. Additionally four parents mentioned that they worked in 
health related careers. This may have had an influence on their knowledge and 
or their perception of HPV vaccine. Lastly, a considerable proportion of parents 
born outside the US were from low resource countries, in which vaccinations in 
non-medical settings (e.g. schools) is common, which may have skewed the 
results obtained.  
Because physician’s recommendations continue to be a primary factor in 
whether or not parents will vaccinate their daughters, and parents seemed to 
retain very little from their discussions of the vaccine, future studies should seek 
to look at parent physician discussions. Specifically, researchers should focus on 
the information and the approach doctors’ use when recommending the vaccine 
to their patients in order to determine how to decrease the missed opportunities.   
 
 
 44 
LIST OF JOURNAL ABBREVIATIONS  
 
Am. J. Prev. Med. American Journal of Preventive Medicine 
BMC Pediatr.  BMC Pediatrics 
BMC Public Health BMC Public Health  
BMC Women BMC women’s health 
Health 
Int. Nurs. Rev.  International Nursing Review  
J. Health. Commun. Journal of Health Communication  
J. Oncol.  Journal of Oncology 
J. Pediatr.   Journal of pediatric and adolescent gynecology 
Adol. Gynec.  
J. Pediatr.  The Journal of Pediatrics  
J. Womens Health  Journal of Women’s Health  
Pediatrics.   Pediatrics 
Vaccine.  Vaccine  
Women Health Iss.  Women’s Health Issues  
 
 45 
REFERENCES 
 
Allen, J. D., De Jesus, M., Mars, D., Tom, L., Cloutier, L., & Shelton, R. C. (2012). 
Decision-Making about the HPV Vaccine among Ethnically Diverse Parents: 
Implications for Health Communications. Journal of Oncology, 2012, 1–5. 
doi:10.1155/2012/401979 
 
CDC - HPV-Associated Cancers Diagnosis by Age. (n.d.). Retrieved February 11, 
2013, from http://www.cdc.gov/cancer/hpv/statistics/age.htm 
 
CDC - HPV-Associated Cancers Rates by Race and Ethnicity. (n.d.). Retrieved 
February 11, 2013, from http://www.cdc.gov/cancer/hpv/statistics/race.htm 
 
CDC - HPV-Associated Cancers Statistics. (n.d.). Retrieved February 11, 2013, from 
http://www.cdc.gov/cancer/hpv/statistics/ 
 
CDC - Number of HPV-Associated Cancer Cases per Year. (n.d.). Retrieved 
February 11, 2013, from http://www.cdc.gov/cancer/hpv/statistics/cases.htm 
 
CDC - Teen Vaccination Coverage - NIS – Teen - Vaccines. (n.d.). Retrieved 
February 20, 2013, from http://www.cdc.gov/vaccines/who/teens/vaccination-
coverage.html 
 
Culp, L., & Caucci, L. (2013). State Adolescent Consent Laws and Implications for 
HIV Pre-Exposure Prophylaxis. American Journal of Preventive Medicine, 44(1, 
Supplement 2), S119–S124. doi:10.1016/j.amepre.2012.09.044 
 
Davis, M. M., & Gaglia, M. A. (2005). Associations of daycare and school entry 
vaccination requirements with varicella immunization rates. Vaccine, 23, 3053- 
3060. 
 
Dempsey, A. F., Zimet, G. D., Davis, R. L., & Koutsky, L. (2006). Factors That Are 
Associated With Parental Acceptance of Human Papillomavirus Vaccines: A 
Randomized Intervention Study of Written Information About HPV. Pediatrics, 
117(5), 1486–1493. doi:10.1542/peds.2005-1381 
 
FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in 
females and updated HPV vaccination recommendations from the Advisory 
Committee on Immunization Practices (ACIP). (2010). MMWR. Morbidity and 
mortality weekly report, 59(20), 626–629. 
 
Haber, G., Malow, R. M., & Zimet, G. D. (2007). The HPV vaccine mandate 
controversy. Journal of pediatric and adolescent gynecology, 20(6), 325–331. 
doi:10.1016/j.jpag.2007.03.101 
 46 
Harper, D. M., & Paavonen, J. (2008). Age for HPV vaccination. Vaccine, 26, 
Supplement 1, A7–A11. doi:10.1016/j.vaccine.2008.01.013 
 
Hopkins, T. G., & Wood, N. (n.d.). Female human papillomavirus (HPV) vaccination: 
Global uptake and the impact of attitudes. Vaccine. 
doi:10.1016/j.vaccine.2013.01.028 
 
HPV Vaccine: State Legislation and Statutes. (n.d.). Retrieved February 21, 2013, 
from http://www.ncsl.org/issues-research/health/hpv-vaccine-state-legislation-
and-statutes.aspx 
 
Hughes, C. C., Jones, A. L., Feemster, K. A., & Fiks, A. G. (2011). HPV vaccine 
decision making in pediatric primary care: a semi-structured interview study. 
BMC pediatrics, 11, 74. doi:10.1186/1471-2431-11-74 
 
Iloka, S. U. (2008). Racial and sociodemographic barriers related to parental 
acceptability of the human papillomavirus vaccine. Thesis MA--Boston University. 
 
Javanbakht, M., Stahlman, S., Walker, S., Gottlieb, S., Markowitz, L., Liddon, N., … 
Guerry, S. (2012). Provider perceptions of barriers and facilitators of HPV 
vaccination in a high-risk community. Vaccine, 30(30), 4511–4516. 
doi:10.1016/j.vaccine.2012.04.062 
 
Joseph, N. P., Clark, J. A., Bauchner, H., Walsh, J. P., Mercilus, G., Figaro, J., … 
Perkins, R. B. (2012). Knowledge, Attitudes, and Beliefs Regarding HPV 
Vaccination: Ethnic and Cultural Differences Between African-American and 
Haitian Immigrant Women. Women’s Health Issues, 22(6), e571–e579. 
doi:10.1016/j.whi.2012.09.003 
 
Kennedy, A., Sapsis, K. F., Stokley, S., Curtis, C. R., & Gust, D. (2011). Parental 
Attitudes Toward Human Papillomavirus Vaccination: Evaluation of an 
Educational Intervention, 2008. Journal of Health Communication, 16(3), 300–
313. doi:10.1080/10810730.2010.532296 
 
Kessels, S. J. M., Marshall, H. S., Watson, M., Braunack-Mayer, A. J., Reuzel, R., & 
Tooher, R. L. (2012). Factors associated with HPV vaccine uptake in teenage 
girls: A systematic review. Vaccine, 30(24), 3546–3556. 
doi:10.1016/j.vaccine.2012.03.063 
 
LaMontagne, D. S., Barge, S., Le, N. T., Mugisha, E., Penny, M. E., Gandhi, S., … 
Jumaan, A. O. (2011). Human papillomavirus vaccine delivery strategies that 
achieved high coverage in low- and middle-income countries. Estrategias para el 
suministro de la vacuna del virus del papiloma humano que consiguieron una 
alta cobertura en países con ingresos bajos y medios., 89(11), 821–830. 
 47 
Markowitz, L. E., Dunne, E. F., Saraiya, M., Lawson, H. W., Chesson, H., & Unger, E. 
R. (2007). Quadrivalent Human Papillomavirus Vaccine: Recommendations of 
the Advisory Committee on Immunization Practices (ACIP). MMWR. 
Recommendations and reports: Morbidity and mortality weekly report. 
Recommendations and reports / Centers for Disease Control, 56(RR-2), 1–24. 
 
Mather, T., McCaffery, K., & Juraskova, I. (2012). Does HPV vaccination affect 
women’s attitudes to cervical cancer screening and safe sexual behaviour? 
Vaccine, 30(21), 3196–3201. doi:10.1016/j.vaccine.2012.02.081 
 
Mayne, S., Karavite, D., Grundmeier, R. W., Localio, R., Feemster, K., Debartolo, E., 
… Fiks, A. G. (2012). The Implementation and Acceptability of an HPV 
Vaccination Decision Support System Directed at Both Clinicians and Families. 
AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium, 
2012, 616–624. 
 
Glory N. Mercilus. (2009). Racial aspects associated with human papillomavirus 
vaccine acceptability in African American and Haitian women. Thesis MA--
Boston University. 
 
Morita, J. Y., Ramirez, E., & Trick, W. E. (2008). Effect of a school-entry vaccination 
requirement on racial and ethnic disparities in hepatitis B immunization coverage 
levels among public school students. Pediatrics,121, e547– e552. 
 
Mortensen, G. L. (2010). Drivers and barriers to acceptance of human-papillomavirus 
vaccination among young women: a qualitative and quantitative study. BMC 
public health, 10, 68. doi:10.1186/1471-2458-10-68 
 
National and State Vaccination Coverage Among Adolescents Aged 13–17 Years — 
United States, 2011. (n.d.). Retrieved March 20, 2013, from 
http://www.cdc.gov.ezproxy.bu.edu/mmwr/preview/mmwrhtml/mm6134a3.htm?s_
cid=mm6134a3_e%0d%0a 
 
Perkins, R. B., Brogly, S. B., Adams, W. G., & Freund, K. M. (2012). Correlates of 
Human Papillomavirus Vaccination Rates in Low-Income, Minority Adolescents: 
A Multicenter Study. Journal of Women’s Health, 21(8), 813–820. 
doi:10.1089/jwh.2011.3364 
 
Perkins, R. B., & Clark, J. A. (2012). What Affects Human Papillomavirus Vaccination 
Rates? A Qualitative Analysis of Providers’ Perceptions. Women’s Health Issues, 
22(4), e379–e386. doi:10.1016/j.whi.2012.04.001 
 
Perkins, R. B., Pierre-Joseph, N., Marquez, C., Iloka, S., & Clark, J. A. (2010a). Why 
Do Low-Income Minority Parents Choose Human Papillomavirus Vaccination for 
 48 
Their Daughters? The Journal of Pediatrics, 157(4), 617–622. 
doi:10.1016/j.jpeds.2010.04.013 
 
Perkins, R. B., Pierre-Joseph, N., Marquez, C., Iloka, S., & Clark, J. A. (2010b). 
Parents’ Opinions of Mandatory Human Papillomavirus Vaccination: Does 
Ethnicity Matter? Women’s Health Issues, 20(6), 420–426. 
doi:10.1016/j.whi.2010.07.001 
 
Pitts, M. J., & Adams Tufts, K. (2012). Implications of the Virginia Human 
Papillomavirus Vaccine Mandate for Parental Vaccine Acceptance. Qualitative 
health research. doi:10.1177/1049732312470871 
 
Rosenthal, S. L., Weiss, T. W., Zimet, G. D., Ma, L., Good, M. B., & Vichnin, M. D. 
(2011). Predictors of HPV vaccine uptake among women aged 19-26: 
importance of a physician’s recommendation. Vaccine, 29(5), 890–895. 
doi:10.1016/j.vaccine.2009.12.063 
 
STD Facts - Human papillomavirus (HPV). (n.d.). Retrieved February 23, 2013, from 
http://www.cdc.gov/std/HPV/STDFact-HPV.htm 
 
Thompson, J. (2007). Human papillomavirus vaccine  : a path to prevention. Thesis 
MA--Boston University. 
 
Vadaparampil, S. T., Kahn, J. A., Salmon, D., Lee, J.-H., Quinn, G. P., Roetzheim, R., 
… Giuliano, A. R. (2011). Missed clinical opportunities: provider 
recommendations for HPV vaccination for 11-12 year old girls are limited. 
Vaccine, 29(47), 8634–8641. doi:10.1016/j.vaccine.2011.09.006 
 
vis-hpv-gardasil.pdf. (n.d.). Retrieved from 
http://www.cdc.gov/vaccines/pubs/vis/downloads/vis-hpv-gardasil.pdf 
 
Walhart, T. (2012). Parents, adolescents, children and the human papillomavirus 
vaccine: a review. International Nursing Review, 59(3), 305–311. 
doi:10.1111/j.1466-7657.2012.00991.x 
 
Zimet, G. D., Weiss, T. W., Rosenthal, S. L., Good, M. B., & Vichnin, M. D. (2010). 
Reasons for non-vaccination against HPV and future vaccination intentions 
among 19-26 year-old women. BMC women’s health, 10, 27. doi:10.1186/1472-
6874-10-27 
 
 
 49 
VITA  
 
 
 
 
 
 
 
 
 
 
           
  
  
 
         
  
 
  
  
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
  
  
  
 
 
 
  
 50 
  
  
 
 
 
 
  
 
  
 
 
 
 
 
   
  
 
 
 
 
  
 
 
 
  
 
  
  
 
 
 
 
  
  
 
  
 
 
 
  
 
  
